CompletedNot Applicable

Short-term Outcomes of ERAS Protocol in RAME for Esophageal Cancer

China211 participantsStarted 2019-01-01

Plain-language summary

This single-center, retrospective cohort study aimed to evaluate the short-term outcomes of enhanced recovery after surgery (ERAS) protocol in perioperative robotic-assisted McKeown esophagectomy (RAME) among esophageal cancer patients.

Who can participate

Age range20 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. first detected and endoscopically confirmed esophageal cancer;
✓. preoperative evaluation showed no distant metastases and suitable for RAME;
✓. preoperative clinical stage of I to III;

Exclusion criteria

✕. patients had a history of thoracic or abdominal surgery;
✕. patients were IV to VI in the American Society of Anesthesiologists (ASA) physical status classification system;
✕. patients had other malignancies;
✕. patients had missing clinical data

What they're measuring

time to first flatus

Timeframe: 2019-2022

time to out-of-bed activity

Timeframe: 2019-2022

time to liquid diet

Timeframe: 2019-2022

postoperative pain score

Timeframe: 2019-2022

duration of analgesic pump

Timeframe: 2019-2022

postoperative hospital stay

Timeframe: 2019-2022

ICU length of stay

Timeframe: 2019-2022

in-hospital mortality

Timeframe: 2019-2022

incidence of various postoperative complications

Timeframe: 2019-2022

Trial details

NCT IDNCT05600335

SponsorWest China Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2021-08-16

View on ClinicalTrials.gov More Esophageal Cancer Patients trials